The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis

Göster/ Aç
Erişim
info:eu-repo/semantics/closedAccessTarih
2017Yazar
Küçük, AdemUslu, Ali Uğur
İçli, Abdullah
Cüre, Erkan
Arslan, Şevket
Türkmen, Kultiin
Toker, Aysun
Kayrak, Mehmet
Üst veri
Tüm öğe kaydını gösterKünye
Küçük, A., Uslu, A.U., İçli, A., Cüre, E., Arslan, S., Türkmen, K., Toker, A. & Kayrak, M. (2017). The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis. Zeitschrift Fur Rheumatologie, 76(1), 58-63. https://doi.org/10.1007/s00393-016-0092-4Özet
In ankylosing spondylitis (AS) patients, cardiac and vascular involvement may manifest as atherosclerosis and coronary artery disease. Systemic inflammation, oxidative stress, increased low-density lipoprotein (LDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol constitute a significant risk for atherosclerosis. This study investigated the relationship between carotid intima-media thickness (CIMT), LDL/HDL ratio, total oxidant status (TOS; an indicator of oxidative stress) and ischemic modified albumin (IMA; an ischemic marker in AS patients). Sixty AS patients were diagnosed using the Modified New York Criteria; 54 age- and gender-matched participants were included as controls. CIMT, LDL/HDL ratio, TOS and IMA were measured using the most appropriate methods. IMA was higher in AS patients compared to controls (p < 0.0001). TOS was also increased in AS patients (p = 0.005); as was CIMT (p < 0.0001). the LDL/HDL ratio was also greater in AS patients compared to controls (p = 0.047). A positive correlation was found between CIMT and LDL/HDL ratio among AS patients. Elevated CIMT, IMA and TOS levels suggest an increased risk of atherosclerotic heart disease in AS patients. the LDL/HDL ratio was higher in AS patients compared to controls, and there was a correlation between LDL/HDL ratio and CIMT, albeit statistically weak. Therefore, the LDL/HDL ratio is not a reliable marker to predict atherosclerotic heart disease in AS patients.